MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA, INC., and AKORN INC., Petitioners v. ALLERGAN, INC., Patent Owner | Association for Accessible Medicines
AAM Amicus Brief

MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA, INC., and AKORN INC., Petitioners v. ALLERGAN, INC., Patent Owner

In an amicus brief submitted to the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trade Office, AAM urged the PTAB to reject Allergan’s effort to avoid the PTAB review of the validity of its patents by renting the sovereign immunity of the St. Regis Mohawk Tribe. Brand name drug companies who abuse the patent system harm patients by forcing them to pay monopoly prices far longer than they should.

View Brief

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.